SCHEMBL778177

SCHEMBL778177

Clc1nc(N2CCCCC2)nc(N2CCNCC2)n1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.81
SMN1; SMN2 Q16637 1/20 0.81
TDP1 Q9NUW8 1/20 0.81
HRH1 P35367 1/20 0.77
CASP1 P29466 1/20 0.59
CASP4 P49662 1/20 0.59
CASP5 P51878 1/20 0.59
PDE4A P27815 2/20 0.53
PDE4B Q07343 2/20 0.53
PDE4C Q08493 2/20 0.53
PDE4D Q08499 2/20 0.53
KDM4E B2RXH2 2/20 0.53
ALDH1A1 P00352 2/20 0.53
HRH4 Q9H3N8 1/20 0.44
CETP P11597 2/20 0.44
MEN1 O00255 1/20 0.44
HTT P42858 1/20 0.44
RECQL P46063 1/20 0.44
KMT2A Q03164 1/20 0.44
ATM Q13315 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL778188 0.90 SMN1; SMN2 (1.00) USP2SMN1; SMN2TDP1HRH1CASP1
SCHEMBL5712191 0.88 HRH1 (0.61) USP2SMN1; SMN2TDP1HRH1CASP1
SCHEMBL28998684 0.88 SMN1; SMN2 (0.58) USP2SMN1; SMN2TDP1HRH1KDM4E
SCHEMBL8542091 0.88 HRH1 (1.00) USP2SMN1; SMN2TDP1HRH1CASP1
SCHEMBL1090112 0.88 SMN1; SMN2 (0.58) USP2SMN1; SMN2TDP1HRH1KDM4E
SCHEMBL8422457 0.88 SMN1; SMN2 (0.58) USP2SMN1; SMN2TDP1HRH1KDM4E
SCHEMBL9073359 0.85 HRH1 (0.56) USP2SMN1; SMN2TDP1HRH1ALDH1A1
SCHEMBL778332 0.83 SMN1; SMN2 (0.52) USP2SMN1; SMN2TDP1HRH1CASP1
SCHEMBL2242665 0.83 SMN1; SMN2 (0.52) USP2SMN1; SMN2TDP1HRH1CASP1
SCHEMBL777891 0.81 HRH1 (0.55) USP2SMN1; SMN2TDP1HRH1CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150057395-A1 Polytriazinyl Compounds as Flame Retardants and Light Stabilizers MCA TECHNOLOGIES GMBH (CH) 2015-02-26 US disclosed
US-20140011923-A1 Polytriazinyl Compounds as Flame Retardants and Light Stabilizers MCA TECHNOLOGIES GMBH (CH) 2014-01-09 US disclosed
US-20120245291-A1 Polytriazinyl Compounds as Flame Retardants and Light Stabilizers MCA TECHNOLOGIES GMBH (CH) 2012-09-27 US disclosed
US-8202924-B2 Polytriazinyl compounds as flame retardants and light stabilizers MCA TECHNOLOGIES GMBH (CH) 2012-06-19 US disclosed
US-20120071594-A1 POLYTRIAZINYL COMPOUNDS AS FLAME RETARDANTS AND LIGHT STABILIZERS MCA TECHNOLOGIES GMBH (CH) 2012-03-22 US disclosed
US-20090281215-A1 Polytriazinyl Compounds as Flame Retardants and Light Stabilizers MCA TECHNOLOGIES GMBH (CH) 2009-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071594-A1 POLYTRIAZINYL COMPOUNDS AS FLAME RETARDANTS AND LIGHT STABILIZERS PCBP1, PBRM1, TAF5 USP2 1267/4885SMN1; SMN2 2588/4885TDP1 473/4885
US-20090281215-A1 Polytriazinyl Compounds as Flame Retardants and Light Stabilizers PSMB5, POLL, F12 USP2 807/4885SMN1; SMN2 1885/4885TDP1 1726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.